The clinical feathers of phaechromocytoma and paraganglioma with normal plasmal free MNs

Wanli Cao,Baoxing Huang,Kang Cheng,Hengchuan Su,Xin Huang,Jun Dai,Wenlong Zhou,Yu Zhu,Zhoujun Shen,Xiaochun Fei,Guang Ning,Fukang Sun
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2015.02.005
2015-01-01
Abstract:Objective This research is to increase our ability to make more accurate diagnosis about phaechromocytoma and paraganglioma (PPGLs) patients with normal plasma free MNs. Methods A retrospective research was conducted in our hospital’ selectronic data base recorded from 2004 to 2012, where pathological confirmed phaechromocytoma(Pheos) and paragangliomas (PGLs) patients were included for analyzing the clinical symptoms and signs, endocrine hormone level, enhanced-contrast CT and radionuclide imaging feathers. Patients were assigned to Group 1 with normal plasma free MNs and Group 2 with elevated plasma free MNs. The above characteristics were compared between both groups. Results 189 patients were included for comprehensive analysis, of which 24 patients were enrolled into Group 1. The prevalence of hypertension, paroxysmal hypertension, no less than two symptoms of paroxysmal episodes of headache, sweating and palpitations, weight losses in Group 1 were significantly lower than patients in Group 2 (P<0.05). The average 24-h urinary epinephrine, dopamine and norepinephrine in Group 1 were lower than the matched group, especially for the average 24-h urinary norepinephrine, which was 1/6 that of patients in Group 2 (P=0.001). Despite the prevalence of hyperattenuation and heterogenous enhancement decreased by 14.8% compared to that of patients in Group 2 (P=0.101), it was still predominant among all enhancement patterns of enhanced-contrast CT in Group 1. There was no significant difference when it came to the prevalence of all kinds of enhance patterns on enhanced-contrast CT between both groups (P>0.05). Radionuclide imaging showed a similar positive detecting rate between two groups (P=1.000). Conclusion The suspicious clinical symptoms and signs for PPGLs were not that apparent in PPGLs patients with normal plasma free MNs, who were associated with a decreased catecholamine secretion. Hyperattenuation and heterogenous enhancement at enhanced-contrast CT or positive radionuclide imaging may attribute to a more accurate diagnosis of those patients than biochemical tests.
What problem does this paper attempt to address?